NASDAQ:INBS Intelligent Bio Solutions - INBS Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Intelligent Bio Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.82 -0.14 (-14.60%) (As of 01/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.75▼$0.8850-Day Range$0.19▼$1.2452-Week Range$0.17▼$1.60Volume2.05 million shsAverage Volume9.52 million shsMarket Capitalization$15.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial Media About Intelligent Bio Solutions (NASDAQ:INBS) StockIntelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Read More Receive INBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter. Email Address INBS Stock News HeadlinesJanuary 27, 2023 | americanbankingnews.comReviewing Intelligent Bio Solutions (INBS) and Its PeersJanuary 23, 2023 | finanznachrichten.deIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform DevelopmentJanuary 29, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…January 23, 2023 | marketwatch.comIntelligent Bio Sees Improvement in Biosensor-Platform Development StudyJanuary 23, 2023 | marketwatch.comIntelligent Bio Shares Quadruple After Improvement in Biosensor-Platform DevelopmentJanuary 23, 2023 | finance.yahoo.comIntelligent Bio Solutions Reaches Key Milestone in Biosensor Platform DevelopmentJanuary 22, 2023 | americanbankingnews.comComparing Intelligent Bio Solutions (INBS) & The CompetitionJanuary 21, 2023 | morningstar.comIntelligent Bio Solutions Inc Ordinary SharesJanuary 29, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…January 5, 2023 | finance.yahoo.comINBS: It’s Touch and Go From HereJanuary 5, 2023 | finance.yahoo.comIntelligent Bio Solutions Inc. Reports First Quarter Ending September 30, 2022, Preliminary Financial Results and Recent Business HighlightsJanuary 5, 2023 | finance.yahoo.comIntelligent Bio Solutions Inc. Announces Cancellation of FY 2021 Annual Meeting of StockholdersJanuary 5, 2023 | finance.yahoo.comIntelligent Bio Solutions Inc. Announces Closing of Private Placement OfferingSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive INBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter. Email Address INBS Company Calendar Today1/29/2023Fiscal Year End6/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:INBS CUSIPN/A CIK1725430 Webgbs.inc Phone646-828-8258FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,310,000.00 Net Margins-1,078.91% Pretax Margin-1,082.78% Return on Equity-106.09% Return on Assets-62.08% Debt Debt-to-Equity RatioN/A Current Ratio3.48 Quick Ratio3.48 Sales & Book Value Annual Sales$440,000.00 Price / Sales34.16 Cash FlowN/A Price / Cash FlowN/A Book Value$0.44 per share Price / Book1.86Miscellaneous Outstanding Shares18,350,000Free Float18,006,000Market Cap$15.03 million OptionableNot Optionable Beta1.47 Key ExecutivesMr. Harry Simeonidis (Age 55)Pres & CEO Comp: $354.71kMr. Spiro Kevin Sakiris B.Bus (Age 60)C.A., CA, Dip Law, Chief Financial Officer Comp: $292.45kMs. Victoria Gavrilenko (Age 39)Operations Mang. Mr. Alex ArzenoVP of Investor RelationsKey CompetitorsPlus TherapeuticsNASDAQ:PSTVNeuroMetrixNASDAQ:NUROFemasysNASDAQ:FEMYPolyPidNASDAQ:PYPDNephrosNASDAQ:NEPHView All Competitors INBS Stock - Frequently Asked Questions How have INBS shares performed in 2023? Intelligent Bio Solutions' stock was trading at $0.1999 on January 1st, 2023. Since then, INBS stock has increased by 309.7% and is now trading at $0.8190. View the best growth stocks for 2023 here. What is Intelligent Bio Solutions' stock symbol? Intelligent Bio Solutions trades on the NASDAQ under the ticker symbol "INBS." How do I buy shares of Intelligent Bio Solutions? Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Intelligent Bio Solutions' stock price today? One share of INBS stock can currently be purchased for approximately $0.82. How much money does Intelligent Bio Solutions make? Intelligent Bio Solutions (NASDAQ:INBS) has a market capitalization of $15.03 million and generates $440,000.00 in revenue each year. The company earns $-8,310,000.00 in net income (profit) each year or ($0.56) on an earnings per share basis. How can I contact Intelligent Bio Solutions? Intelligent Bio Solutions' mailing address is 142 WEST 57TH ST FL11, NEW YORK NY, 10019. The official website for the company is gbs.inc. The company can be reached via phone at 646-828-8258 or via email at investor.relations@gbs.inc. This page (NASDAQ:INBS) was last updated on 1/29/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.